The global arterial cannula market has witnessed remarkable growth, reaching a market value of USD 21 billion in 2023. With a robust compound annual growth rate (CAGR) of 6.6%, this market is ...

Rising Frequency of Chronic Diseases to Drive the Market for Arterial Cannula: FMI Study. Asia Pacific Arterial Cannula Market is expected to grow at a CAGR of 6.1% in the assessment period 2023 ...

A recently published study by FMI expects the global arterial cannula market for arterial cannulas was valued at US$ 21 billion in 2023, and between 2022 to 2033, it is anticipated to grow at a CAGR ...

This is a case of an unusually difficult thrombectomy of the brachial artery after occlusion following withdrawal of the arterial cannula placed for monitoring during cardiac surgery.

The arterial cannula (26G BD Neoflon) was connected to an intravenous (IV) tubing (RMS infusion set, Romsons, Agra, India), which was already cut to one-fourth its length, and its volume measured ...

LivaNova PLC announced its Bi-Flow ECMO earned CE Mark for ECMO procedures where femoral artery cannulation can be applied.

The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.2% over the forecast period.

LivaNova PLC today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia during cardiac surgery.

Explore key insights on the Arterial Cannula Market, including growth trends, demand drivers, and forecasts from 2023 to 2033. Europe's National Health Strategy aims to reduce cardiovascular risks ...

LivaNova PLC, a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation cannula earned CE Mark approval for ECMO procedures where ...